Response: Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled ‐release carbamazepine in noninferiority epilepsy monotherapy trials: How much “fair” is “fair”

Epilepsia,Volume 59, Issue 4, Page 900-901, April 2018.

Source: Epilepsia - March 31, 2018 Category: Neurology Source Type: research